Evidence map›Paper›PMID 28981531›Full record

ArticlePloS one2017

Identification and characterization of new isoforms of human fas apoptotic inhibitory molecule (FAIM).

Elena Coccia, Isabel Calleja-Yagüe, Laura Planells-Ferrer, Blanca Sanuy, Belen Sanz, Joaquin López-Soriano, Rana S Moubarak, Francina Munell, Bruna Barneda-Zahonero, Joan X Comella and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. FAIM-L - SIVA-1: Two Modulators of XIAP in Non-Apoptotic Caspase Function.Frontiers in cell and developmental biology · 2021
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Elena CocciaCell Signaling and Apoptosis Group, Vall d´Hebron Institute of Research (VHIR), Barcelona, Spain.
Isabel Calleja-YagüeCell Signaling and Apoptosis Group, Vall d´Hebron Institute of Research (VHIR), Barcelona, Spain.
Laura Planells-FerrerCell Signaling and Apoptosis Group, Vall d´Hebron Institute of Research (VHIR), Barcelona, Spain.
Blanca SanuyCell Signaling and Apoptosis Group, Vall d´Hebron Institute of Research (VHIR), Barcelona, Spain.
Belen SanzCell Signaling and Apoptosis Group, Vall d´Hebron Institute of Research (VHIR), Barcelona, Spain.
Joaquin López-SorianoCell Signaling and Apoptosis Group, Vall d´Hebron Institute of Research (VHIR), Barcelona, Spain.
Rana S MoubarakCell Signaling and Apoptosis Group, Vall d´Hebron Institute of Research (VHIR), Barcelona, Spain.
Francina MunellPediatric Neurology Group, Vall d´Hebron Institute of Research (VHIR), Barcelona, Spain.
Bruna Barneda-ZahoneroCell Signaling and Apoptosis Group, Vall d´Hebron Institute of Research (VHIR), Barcelona, Spain.
Joan X ComellaCell Signaling and Apoptosis Group, Vall d´Hebron Institute of Research (VHIR), Barcelona, Spain.
M Jose Pérez-GarcíaCell Signaling and Apoptosis Group, Vall d´Hebron Institute of Research (VHIR), Barcelona, Spain.ORCID http://orcid.org/0000-0001-9014-7986
Universitat Autònoma de Barcelona · ESVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fas Apoptosis Inhibitory Molecule (FAIM) is an evolutionarily highly conserved death receptor antagonist, widely expressed and known to participate in physiological and pathological processes. Two FAIM transcript variants have been characterized to date, namely FAIM short (FAIM-S) and FAIM long (FAIM-L). FAIM-S is ubiquitously expressed and serves as an anti-apoptotic protein in the immune system. Furthermore, in neurons, this isoform promotes NGF-induced neurite outgrowth through NF-кB and ERK signaling. In contrast FAIM-L is found only in neurons, where it exerts anti-apoptotic activity against several stimuli. In addition to these two variants, in silico studies point to the existence of two additional isoforms, neither of which have been characterized to date. In this regard, here we confirm the presence of these two additional FAIM isoforms in human fetal brain, fetal and adult testes, and placenta tissues. We named them FAIM-S_2a and FAIM-L_2a since they have the same sequence as FAIM-S and FAIM-L, but include exon 2a. PCR and western blot revealed that FAIM-S_2a shows ubiquitous expression in all the tissues and cellular models tested, while FAIM-L_2a is expressed exclusively in tissues of the nervous system. In addition, we found that, when overexpressed in non-neuronal cells, the splicing factor nSR100 induces the expression of the neuronal isoforms, thus identifying it as responsible for the generation of FAIM-L and FAIM-L_2a. Functionally, FAIM-S_2a and FAIM-L_2a increased neurite outgrowth in response to NGF stimulation in a neuronal model. This observation thus, supports the notion that these two isoforms are involved in neuronal differentiation. Furthermore, subcellular fractionation experiments revealed that, in contrast to FAIM-S and FAIM-L, FAIM-S_2a and FAIM-L_2a are able to localize to the nucleus, where they may have additional functions. In summary, here we report on two novel FAIM isoforms that may have relevant roles in the physiology and pathology of the nervous system.

Indexed as

Alternative SplicingAnimalsApoptosis Regulatory ProteinsCell LineExonsHumansNucleic Acid ConformationPC12 CellsProtein IsoformsProtein StabilityRatsReal-Time Polymerase Chain ReactionRNA, MessengerThermodynamicsApoptosis Regulatory ProteinsFAIM protein, humanProtein IsoformsRNA, Messenger

Identifiers

PMID28981531
PMCPMC5628826
OpenAlexW2761070936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.